LEXICON PHARMACEUTICALS (LXRX) Covered Calls

LEXICON PHARMACEUTICALS covered calls Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease.

You can sell covered calls on LEXICON PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for LXRX (prices last updated Mon 4:16 PM ET):

LEXICON PHARMACEUTICALS (LXRX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.15 -0.18 12.05 13.05 316K - 1.3B
Covered Calls For LEXICON PHARMACEUTICALS (LXRX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 12 0.35 12.70 -5.5% -401.5%
Aug 17 12 0.85 12.20 -1.6% -17.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease. The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. The company uses its proprietary gene knockout technologies and an integrated platform of advanced medical technologies to systematically study the physiological and behavioral functions in mice and assessed the utility of the proteins encoded by the corresponding human genes as potential drug targets. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.